Galenika - business results in 2020: Business growth, preservation of employee safety and consumer trust

In 2020, Galenika a.d. Belgrade has recorded constant growth in all segments of its business. On the Serbian market, the company increased its sales by 19% compared to 2019. Over 2020, Galenika grew more than 50% faster than the market, which additionally strengthened it in the stabile second position in terms of share in the pharmaceutical market of Serbia. The direct result of the new vision and business strategy resulted in the opening process of 6 new markets, while Galenika is already actively present in 10 international markets in the EU, Middle East and Africa, where it increased sales by 68%.